Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2011 | OriginalPaper | Hoofdstuk

9. Hartklachten in de Zwangerschap

Auteurs: Dr. Els Pieper, Dr. Angela Maas, Drs. Marjolein van Mesdag

Gepubliceerd in: Handboek gynaecardiologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Aan de hand van een casus behandelen wij de voor de eerste lijn relevante cardiale problemen die in de zwangerschap kunnen voorkomen. De begeleiding van vrouwen die uitgebreid bekend zijn met cardiale pathologie hoort thuis in de tweede lijn, bij voorkeur in gespecialiseerde tertiaire centra.
Literatuur
1.
go back to reference Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicentre studies of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515–21 PubMedCrossRef Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicentre studies of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515–21 PubMedCrossRef
2.
go back to reference Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31: 2124–32. PubMedCrossRef Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31: 2124–32. PubMedCrossRef
3.
go back to reference Regitz-Zagrosek V, Blomstrom-Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011 (in press). Regitz-Zagrosek V, Blomstrom-Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 2011 (in press).
4.
go back to reference Thorne S, McGregorA, Nelson-Piercy C. Risk of contraception and pregnancy in women with congenital heart disease. Heart 2006; 92: 1520–25. PubMedCrossRef Thorne S, McGregorA, Nelson-Piercy C. Risk of contraception and pregnancy in women with congenital heart disease. Heart 2006; 92: 1520–25. PubMedCrossRef
5.
go back to reference Drenthen W, Pieper PG, Roos-Hesselink JW, Lottum WA van, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Card 2007; 49: 2302-11. CrossRef Drenthen W, Pieper PG, Roos-Hesselink JW, Lottum WA van, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Card 2007; 49: 2302-11. CrossRef
6.
go back to reference Schutte JM, Jonge L de, Schuitemaker NW, Santema JG, Steegers EA, Roosmalen J van. Indirect maternal mortality increases in the Netherlands. Acta Obst et Gynaec 2010; 89: 762–68. CrossRef Schutte JM, Jonge L de, Schuitemaker NW, Santema JG, Steegers EA, Roosmalen J van. Indirect maternal mortality increases in the Netherlands. Acta Obst et Gynaec 2010; 89: 762–68. CrossRef
7.
go back to reference Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97: 1206-12. PubMedCrossRef Silversides CK, Harris L, Haberer K, Sermer M, Colman JM, Siu SC. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97: 1206-12. PubMedCrossRef
8.
go back to reference Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease. Eur Heart J 2007; 28(2): 230–68. PubMed Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease. Eur Heart J 2007; 28(2): 230–68. PubMed
9.
go back to reference Lesniak-Sobelga A, Tracs W, KostKiewicz M, Podolec P, Pasowicz M. Clinical and echocardiographic assessment of pregnant women with valvular heart disease - maternal and fetal outcome. Int J Card 2004; 94: 15–23. CrossRef Lesniak-Sobelga A, Tracs W, KostKiewicz M, Podolec P, Pasowicz M. Clinical and echocardiographic assessment of pregnant women with valvular heart disease - maternal and fetal outcome. Int J Card 2004; 94: 15–23. CrossRef
10.
go back to reference Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003; 91: 1382–85. PubMedCrossRef Silversides CK, Colman JM, Sermer M, Siu SC. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol 2003; 91: 1382–85. PubMedCrossRef
11.
go back to reference Elkayam U, Bitar F. Valvular heart disease and pregnancy part 1. Native valves. J Am Coll Card 2005; 46: 223–30. CrossRef Elkayam U, Bitar F. Valvular heart disease and pregnancy part 1. Native valves. J Am Coll Card 2005; 46: 223–30. CrossRef
12.
go back to reference Pieper PG. Expected and unexpected problems during pregnancy. Editorial. Neth Heart J 2008;16: 403–5. PubMedCrossRef Pieper PG. Expected and unexpected problems during pregnancy. Editorial. Neth Heart J 2008;16: 403–5. PubMedCrossRef
13.
go back to reference James PR, Nelson-Piercy C. Management of hypertension before, during and after pregnancy. Heart; 90: 1499-1504. James PR, Nelson-Piercy C. Management of hypertension before, during and after pregnancy. Heart; 90: 1499-1504.
14.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974–83. PubMedCrossRef Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974–83. PubMedCrossRef
15.
go back to reference Drost JT, Arpaci G, vanb Eyck J, Maas AHEM. Hoge bloeddruk in de zwangerschap. Belangrijke voorspeller voor cardiovasculair risico. Hartbulletin 2010; 41: 47–49. Drost JT, Arpaci G, vanb Eyck J, Maas AHEM. Hoge bloeddruk in de zwangerschap. Belangrijke voorspeller voor cardiovasculair risico. Hartbulletin 2010; 41: 47–49.
16.
go back to reference Ray JG, Vermeulen MJ Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797-803. PubMedCrossRef Ray JG, Vermeulen MJ Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005; 366: 1797-803. PubMedCrossRef
17.
go back to reference McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156: 918–30. PubMedCrossRef McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156: 918–30. PubMedCrossRef
18.
go back to reference Kharazmi E, Dossus L, Rohrmann S, Kaaks R. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 2011; 97: 49–54. PubMedCrossRef Kharazmi E, Dossus L, Rohrmann S, Kaaks R. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart 2011; 97: 49–54. PubMedCrossRef
19.
go back to reference Smith GCS, Wood AM, Pell JP, Hattie J. Recurrent miscarriage is associated with a family history of ischemic heart disease: a retrospective cohort study. BJOG 2011; 118: 557–63. PubMedCrossRef Smith GCS, Wood AM, Pell JP, Hattie J. Recurrent miscarriage is associated with a family history of ischemic heart disease: a retrospective cohort study. BJOG 2011; 118: 557–63. PubMedCrossRef
20.
go back to reference Steegers EAP, Dadelszen P von, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631–44. PubMedCrossRef Steegers EAP, Dadelszen P von, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010; 376: 631–44. PubMedCrossRef
21.
go back to reference Retnakaran R, Ying Q, Zinman B, Sermer M, Hanley A, Conelly P. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010;95: 670–77. PubMedCrossRef Retnakaran R, Ying Q, Zinman B, Sermer M, Hanley A, Conelly P. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010;95: 670–77. PubMedCrossRef
22.
go back to reference Bellamy L, Casas JP, Hingorani AD, Williams DJ. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773–79. PubMedCrossRef Bellamy L, Casas JP, Hingorani AD, Williams DJ. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373: 1773–79. PubMedCrossRef
23.
go back to reference Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women, 2011 update. A guideline from the American Heart Association. Circulation 2011; 123: 1243–62. PubMedCrossRef Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women, 2011 update. A guideline from the American Heart Association. Circulation 2011; 123: 1243–62. PubMedCrossRef
Metagegevens
Titel
Hartklachten in de Zwangerschap
Auteurs
Dr. Els Pieper
Dr. Angela Maas
Drs. Marjolein van Mesdag
Copyright
2011
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8782-3_9